History has been made by scientists at Sunnybrook Health Sciences Centre (ON, Canada) this week as they open the blood-brain barrier for the first time using focused ultrasound.
Browsing: Cognitive/neurodegenerative disorders
New study highlights potential technique for reducing adverse side effects in Alzheimer’s Disease immunotherapy.
This review highlights current research advances and challenges in Pakinson’s disease mild cognitive impairment and looks at lessons to be learned from the more advanced field of Alzheimer’s Disease mild cognitive impairment research.
The Joint Committee for Traceability in Laboratory Medicine have announced a new international standart for the diagnosis of Alzheimer’s disease.
A new wireless system measuring fluctuations in the production of neurotransmitters could provide a way to automatically adjust stimulation patterns in real-time, according to patients’ responses.
This study investigates the use of PEGylated immunoliposomes prepared with anti-transferrin receptor OX26 and anti-α-synuclein LB509 antibodies, in an effort to overcome the blood-brain barrier and reach biological targets of Parkinson’s disease.
Mitochondrial impairment has previously been suggested to have an association with many neurodegenerative disorders. Discover more about how mitochondrial metals are disrupted in neurodegenerative diseases, and potential therapeutics aimed at restoring mitochondrial function.